2.Free jejunal graft for cervical esophageal reconstruction.
The Korean Journal of Thoracic and Cardiovascular Surgery 1991;24(5):515-521
No abstract available.
Transplants*
3.Management of atrial septal defect in patients ages 35 years or older.
Chul Hyun PARK ; Sang Joon OH ; Chang Ho KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 1991;24(12):1161-1166
No abstract available.
Heart Septal Defects, Atrial*
;
Humans
4.The Study for the Outflow Of Aqueous Humor after Injection of Dye into the Anterior Chamber.
Jung Hyub OH ; Sang Joon PARK ; Sang Kyun KIM
Journal of the Korean Ophthalmological Society 1999;40(3):779-783
The aqueous bumor makes an important role to maintain intraocular pressure. The production and outflow of aqueous humor controls the intraocular pressure. The accurate understanding of the pathway of aqueous outflow and the rate of outflow is essential to the study of glaucoma. The purpose of this study is to investigate the pathway of aqueous outflow after injection of dye into the anterior chamber, the duration of staining and the degree of delay of aqueous outflow after the use of viscoelastics. Three dyes. Gentian Violet, Methylene Blue and Viscoelastics mixed with Gentian Violer were injected into the anterior chambers of 20 eyes of 10 rabbits. The eyes were enucleated at 1 hour, 2 hour, 3 hour, 4 hour after injection of Gentian Violer and Methylene Blue. After injiection of viscoelastics mixed with Gentian violet, the eyes were enucleated at 2 hour, 4 hour, 6 hour, 8 hour, and 9 hour. The enucleated eyes were performed for frozen section and the fragments were observed by light microscopee. Gentian violet and Merhylene Blue were stained in the pathway of the pectinate ligaments, trabecular meshwork, intrascleral plexus and the pathway of the capillary network of iris and suprachoroidal space. The disappearance of injected dye was ended between 3 hour and 4 hour. And the viscoelastics mixed with dye was removed between 8 hour and 9 hour. This means that viscoelastics make the outflow of aqueous delay.
Anterior Chamber*
;
Aqueous Humor*
;
Capillaries
;
Coloring Agents
;
Frozen Sections
;
Gentian Violet
;
Gentiana
;
Glaucoma
;
Intraocular Pressure
;
Iris
;
Ligaments
;
Methylene Blue
;
Rabbits
;
Trabecular Meshwork
5.Esophageal perforation during endotracheal intubation.
Sung Chul KIM ; Sang Ik KIM ; Sang Joon OH ; Chang Ho KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 1992;25(11):1231-1235
No abstract available.
Esophageal Perforation*
;
Intubation, Intratracheal*
6.A Clinical Review of the HELLP Syndrome.
Sang Tae AHN ; Haeng Soo KIM ; Jeong In YANG ; Joon Hwan OH ; Ki Su HAN ; Seong Cheon YANG ; Kie Suk OH
Korean Journal of Perinatology 2001;12(2):122-130
No abstract available.
Female
;
HELLP Syndrome*
;
Pregnancy
7.Supravalvular aortic stenosis: report of 3 cases.
Ye Jee JUN ; Shin Yeoung LEE ; Sang Joon OH ; Chang Ho KIM
The Korean Journal of Thoracic and Cardiovascular Surgery 1991;24(3):280-286
No abstract available.
Aortic Stenosis, Supravalvular*
8.The clinical experience of 1000 cases in open heart surgery.
Chung Ki CHUNG ; Bong Suck OH ; Sang Hyung KIM ; Dong Joon LEE
The Korean Journal of Thoracic and Cardiovascular Surgery 1991;24(3):271-279
No abstract available.
Heart*
;
Thoracic Surgery*
9.Dexmedetomidine Use in Patients with 33degrees C Targeted Temperature Management: Focus on Bradycardia as an Adverse Effect.
Hyo Yeon SEO ; Byoung Joon OH ; Eun Jung PARK ; Young Gi MIN ; Sang Cheon CHOI
Korean Journal of Critical Care Medicine 2015;30(4):272-279
BACKGROUND: This study aimed to investigate bradycardia as an adverse effect after administration of dexmedetomidine during 33degrees C target temperature management. METHODS: A retrospective study was conducted on patients who underwent 33degrees C target temperature management in the emergency department during a 49-month study period. We collected data including age, sex, weight, diagnosis, bradycardia occurrence, target temperature management duration, sedative drug, and several clinical and laboratory results. We conducted logistic regression for an analysis of factors associated with bradycardia. RESULTS: A total of 68 patients were selected. Among them, 39 (57.4%) showed bradycardia, and 56 (82.4%) were treated with dexmedetomidine. The odds ratio for bradycardia in the carbon monoxide poisoning group compared to the cardiac arrest group and in patients with higher body weight were 7.448 (95% confidence interval [CI] 1.834-30.244, p = 0.005) and 1.058 (95% CI 1.002-1.123, p = 0.044), respectively. In the bradycardia with dexmedetomidine group, the infusion rate of dexmedetomidine was 0.41 +/- 0.15 microg/kg/h. Decisions of charged doctor's were 1) slowing infusion rate and 2) stopping infusion or administering atropine for bradycardia. No cases required cardiac pacing or worsened to asystole. CONCLUSIONS: Despite the frequent occurrence of bradycardia after administration of dexmedetomidine during 33degrees C target temperature management, bradycardia was completely recovered after reducing infusion rate or stopping infusion. However, reducing the infusion rate of dexmedetomidine lower than the standard maintenance dose could be necessary to prevent bradycardia from developing in patients with higher body weight or carbon monoxide poisoning during 33degrees C targeted temperature management.
Atropine
;
Body Weight
;
Bradycardia*
;
Carbon Monoxide Poisoning
;
Dexmedetomidine*
;
Diagnosis
;
Emergency Service, Hospital
;
Heart Arrest
;
Humans
;
Hypothermia, Induced
;
Logistic Models
;
Odds Ratio
;
Retrospective Studies
10.Anti-HCV EIA by three diagnostic reagent.
Young Chul OH ; Bum Ryoul CHOI ; Hyung Joon BAE ; Ki Hong KIM ; Sang In KIM
Korean Journal of Blood Transfusion 1992;3(1):47-53
No abstract available.